Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Zim Laboratories Limited (NSE: ZIMLAB), ISIN INE518E01015 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ZIMLAB last traded at ₹137.02 (+1.86%), with a 52-week range of ₹59.31 to ₹159.81 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 30.30%, FIIs 0.17%, DIIs 1.19%, mutual funds 1.18%.
EquiSense Score (ECS): 57/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.